Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000380261 | SCV000330009 | pathogenic | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | The c.1300delC pathogenic variant in the KMT2D gene has been reported previously in association with Kabuki syndrome (Miyake et al., 2013). The c.1300delC variant causes a frameshift starting with codon Leucine 434, which changes this amino acid to a premature Stop codon, denoted p.Leu434Ter. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.1300delC variant was not observed in approximately 6,300 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.1300delC as a pathogenic variant. |
Human Developmental Genetics Laboratory, |
RCV002509342 | SCV002820051 | likely pathogenic | Kabuki syndrome 1 | 2023-01-13 | criteria provided, single submitter | research |